Physician profile
Jan Youssef
NPI 1386680635
$1,501.72
in general payments reported to CMS, 2019-2025
17 companies · $400 in 2025
The $400 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $16.91 · 2021: $32.26 · 2022: $343 · 2023: $125 · 2024: $260 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Education: $56.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.70 |
| Education | $56.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $579.52 | 2022-2025 | |
| Acclarent, INC | $283.20 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $109.00 | 2023-2025 | Dupixent |
| Medtronic, INC. | $89.61 | 2024 | Propel |
| Genzyme Corporation | $69.86 | 2022-2025 | |
| Stryker Corporation | $66.37 | 2022-2025 | Xpress Loprofile |
| Sanofi-Aventis U.S. LLC | $56.99 | 2025 | |
| Neurent Medical Limited | $39.25 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Intersect Ent, INC. | $32.26 | 2021 | |
| Optinose US, INC. | $31.64 | 2024 | |
| Fujifilm New Development USA, INC. | $31.31 | 2019 | |
| Integra Lifesciences Corporation | $26.50 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Inspire Medical Systems, INC. | $23.72 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $20.14 | 2023 | Nucala |
| Revance Therapeutics, INC. | $15.13 | 2025 | Daxxify |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.26 | 2019 | |
| Smith+Nephew, INC. | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.